SEC Form 4 research

Summit Therapeutics Inc. insider transactions

Issuer	Summit Therapeutics Inc.
Tickers	SMMT
Reporting owners	21
Officers and directors	6
Last public filing	2026-10-14

Recent insider disclosures

Available	Trade date	Reporting owners	Code	Shares	Price	Reported value
2026-10-14	2026-10-08	Anand Bhaskar	A	100,000	$0	Not reported

Officers and directors in the directory

DUGGAN ROBERT W — 621 qualifying
Dhingra Ankur — 8 qualifying
Powell David Jonathan — 5 qualifying
Soni Manmeet Singh — 30 qualifying
Xia Yu — 1 qualifying
Zanganeh Mahkam — 48 qualifying

Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.